Osaka University Venture Capital logo

Osaka University Venture Capital

Asia, Osaka, Japan, Osaka

Description

Osaka University Venture Capital focuses on early-stage financing in life innovation, green innovation, and platform technology industry.

Investor Profile

Osaka University Venture Capital has backed more than 11 startups, with 7 new investments in the last 12 months alone. The firm has led 2 rounds, about 18% of its total and boasts 4 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series A, Series B rounds (top funding stages).
  • Majority of deals are located in Japan.
  • Strong thematic focus on Biotechnology, Therapeutics, Health Care.
  • Led 2 rounds in the past year.

Stage Focus

  • Seed (36%)
  • Series A (18%)
  • Series B (18%)
  • Series D (9%)
  • Series C (9%)
  • Series Unknown (9%)

Country Focus

  • Japan (100%)

Industry Focus

  • Biotechnology
  • Therapeutics
  • Health Care
  • Medical
  • Life Science
  • Nursing And Residential Care
  • Product Research
  • Pharmaceutical
  • Manufacturing
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Osaka University Venture Capital frequently co-invest with?

RV
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
SkyDeck Berkeley
North America, California, United States, Berkeley
Co-Investments: 1
Mizuho Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 2
Kyoto University Innovation Capital
Asia, Kyoto, Japan, Kyoto
Co-Investments: 2
JIC Venture Growth Investments
Asia, Tokyo, Japan, Marunouchi
Co-Investments: 2
Berkeley SkyDeck Fund
North America, California, United States, Berkeley
Co-Investments: 1
Japan Science and Technology Agency
Asia, Saitama, Japan, Kawaguchi
Co-Investments: 1
SBI Group
Asia, Tokyo, Japan, Tokyo
Co-Investments: 1
Mitsubishi UFJ Capital
Asia, Tokyo, Japan, Tokyo
Co-Investments: 4

What are some of recent deals done by Osaka University Venture Capital?

Celaid Therapeutics

Hongo, Tokyo, Japan

Celaid Therapeutics is a biotech company that develops cell therapies for blood cancer, intractable blood diseases, and genetic disorders.

BiotechnologyHealth CareManufacturingMedicalTherapeutics
Series BOct 7, 2025
Amount Raised: $3,653,876
A-SEEDS

Matsumoto, Nagano, Japan

A-Seeds is a biotech company that researches and develops regenerative medicines, especially for cancer patients.

BiotechnologyGeneticsPharmaceutical
Series AJul 7, 2025
Amount Raised: $15,000,000
EX-Fusion

Osaka, Osaka, Japan

EX-Fusion develops the first commercial laser based nuclear fusion reactor for power generation.

Clean EnergyEnergyLaserNuclear
Series AJun 5, 2025
Amount Raised: $16,032,120
Ayumo

Osaka, Osaka, Japan

Ayumo is a research and development company that provides deep learning services with medical insights and AI technology.

Artificial Intelligence (AI)Market ResearchMedical
SeedApr 15, 2025
Amount Raised: $697,364
RegCell

Osaka, Osaka, Japan

RegCell is a novel therapeutics company.

Alternative MedicineClinical TrialsOutpatient Care
SeedMar 18, 2025
Amount Raised: $8,500,000
QunaSys

Tokyo, Tokyo, Japan

QunaSys is a research and development company that provides design, benchmark, and analyze software using quantum computers.

ComputerConsultingInformation TechnologyQuantum ComputingSoftware
Series BNov 1, 2024
Amount Raised: $11,109,296
A-Wave

Osaka-shi, Osaka, Japan

A-Wave is a manufacturing company that develops and markets medical devices, pharmaceuticals, computer software, and hardware.

Health CareManufacturingMedical Device
Series UnknownOct 15, 2024
Amount Raised: $1,341,492
Alpha Fusion

Osaka, Osaka, Japan

Alpha Fusion produces astatine based radiopharmaceuticals for targeted alpha therapy.

MedicalPharmaceuticalTherapeutics
Series BOct 8, 2024
Amount Raised: $6,885,228
Luxna Biotech

Osaka, Osaka, Japan

Luxana Biotech is established to contribute to medical treatment for suffering patients, .

BiotechnologyHealth CareProduct Research
Series CSep 6, 2024
Amount Raised: $1,686,282
Restore Vision

Tokyo, Tokyo, Japan

Restore Vision is a biotechnology company developing a visual restoration gene therapy for retinitis pigmentosa.

BiotechnologyHealth CareTherapeutics
Series ADec 15, 2023
Amount Raised: $4,221,636